Our findings align with earlier research, demonstrating that SF3B6 was significantly elevated in the majority of tumor tissues, including those from breast cancer, pancreatic cancer, lung cancer, liver cancer, and so on. This evidence concerns the gene SF3B6 and lung carcinoma.